‘Oldest' victim of Horizon IT scandal says ordeal ‘destroyed' her health
Betty Brown, 92, from County Durham, ran the Annfield Plain Post Office near Stanley with her late husband Oswall, in the 1990s and early 2000s.
She claims his death was impacted by the ordeal of missing hundreds of pounds each week in their accounts.
Ms Brown told the PA news agency: 'We had a nice office, nice atmosphere, nice customers, and everything was fine, no problem.
'And then we were told about this wonderful advancement in technology, and we would get a system put in, called Horizon that would half the workload – which it didn't.
'So Horizon was put in, then the very first night, the balance was £500 short, but they thought something had been missed in the accounts or whatever and that was just let go.
'Then it began eventually that there was so many mistakes in the system that it was concerning, and these losses were coming out in amounts of £1,500, £1,600 every week, and we were having to put this money in and make it good, because that's what you sign up for.'
Ms Brown said the ordeal caused her to lose her voice and said the anxiety it caused her husband disrupted his cancer treatment.
He died a year after they sold the Post Office, which Ms Brown said she felt forced to do.
'Even my voice today isn't a voice that I had naturally,' she said.
'The stress, I lost my voice, and after retired, I had to go for elocution lessons, to learn to speak again so that people could understand me.
'The stress was unbelievable. You would go to bed at night and you couldn't sleep.'
Ms Brown and her husband moved away from Annfield Plain to Consett after the ordeal.
'We couldn't live there (Annfield Plain) any longer, because the stigma was there and we kept a low profile.
'We didn't integrate into what the community. We kept ourselves apart. And when people would say to us, what did you do while you were working?
'You evaded the question, and you tried to change the subject.'
Ms Brown continues her campaign for full compensation but said on Tuesday, after the first tranche of the Horizon inquiry's final report was published, that she had an 'amazing' day.
'Sir (Wyn) Williams has done a wonderful job,' Ms Brown said.
'He has felt the pain, he's felt the anxiety, he's felt the agony, he's felt everything that subpostmasters felt and he has been able to bring that with all his skill into a meaningful book.
'I hope that the Post Office will take this on board.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
24 minutes ago
- Medscape
Oximetry Weak for Predicting OSA in Kids With Down Syndrome
TOPLINE: Nocturnal pulse oximetry (NPO) indices, such as the 3% and 4% Oxygen Desaturation Indices (ODI3 and ODI4, respectively), demonstrated moderate sensitivity and specificity for detecting moderate and severe obstructive sleep apnoea (OSA) in children with Down syndrome but showed low sensitivity for detecting mild OSA. METHODOLOGY: Researchers conducted a retrospective study to evaluate the ability of two NPO indices (ODI3 and ODI4) for predicting OSA in children with Down syndrome. They compared cardiorespiratory polygraphy (CRP) and NPO recordings in 387 children aged 2-16 years with Down syndrome (median age, 6.1 years; 46.7% girls) who were referred for the evaluation of OSA at two tertiary sleep centres in the UK between May 2016 and May 2024. OSA was defined as having an Obstructive Apnoea-Hypopnoea Index (OAHI) of one or more events per hour and classified according to severity as mild (one or more to less than five events per hour), moderate (five or more to less than 10 events per hour), or severe (10 or more events per hour). Two-by-two tables were used to determine the sensitivity and specificity of various cutoff values of NPO parameters for predicting OSA: oxygen saturation (SpO2), ODI3, ODI4, minimum SpO2, the Delta 12-second index, and the percentage of analysis time with SpO2 < 94%, < 92%, and < 90%. TAKEAWAY: Of 387 children, 265 (68.5%) had OSA, with 164 (42.4%) having mild OSA, 51 (13.2%) having moderate OSA, and 50 (12.9%) having severe OSA. An ODI3 threshold of 19 or more events per hour provided the highest combined sensitivity and specificity for predicting OSA (59.2% and 74.6%, respectively); increasing the threshold to 23 or more events per hour provided the highest combined sensitivity and specificity for an OAHI of five or more events per hour (70.3% and 79.7%, respectively) and 10 or more events per hour (82.0% and 73.9%, respectively). An ODI4 threshold of 10 or more events per hour yielded moderate sensitivity (76.2%) and specificity (75.2%) for predicting OSA; a threshold of 13 or more events per hour provided moderate sensitivity (72.0%) and high specificity (80.7%) for an OAHI of 10 or more events per hour. For predicting an OAHI of one or more events per hour, an ODI3 threshold of 19 or more events per hour yielded a positive predictive value of 83.5% and a negative predictive value of 45.7%, and an ODI4 of eight or more events per hour yielded a positive predictive value of 82.8% and a negative predictive value of 47.5%. IN PRACTICE: "Oximetry alone does not provide a reliable diagnostic tool for evaluating OSA in children with DS [Down syndrome]; therefore, we recommend CRP/PSG [polysomnography] should be performed," the authors wrote. SOURCE: This study was led by Hannah Vennard, Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children, Glasgow in Glasgow, Scotland. It was published online on August 11, 2025, in Archives of Disease in Childhood. LIMITATIONS: Using CRP instead of polysomnography meant that total sleep time was estimated, which could have potentially led to the underestimation of the OAHI due to underscoring of hypopnoeas not associated with desaturation when arousals from sleep could not be detected. The total recording time of stand-alone oximetry does not match the total sleep time measured using CRP, which may have affected the accuracy of oximetry indices in predicting the OAHI. The high prevalence of central apnoeic events may have affected the accuracy of ODI thresholds for predicting OSA. DISCLOSURES: This study did not receive any funding from any source. The authors declared no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication
Medscape
an hour ago
- Medscape
Beetroot Juice's Blood Pressure Secret: The Nitrate Effect
A study from the University of Exeter, Exeter, England, found that regular consumption of beetroot juice may help lower blood pressure in adults over 60 years of age. Beetroot is naturally rich in micronutrients and minerals, and its nitrate content plays a central role in this effect. Evidence has shown that poor oral health and microbial imbalances can reduce the body's ability to convert dietary nitrate into nitric oxide, a compound essential for blood pressure regulation. These findings highlight the potential cardiovascular benefits of nitrate-rich foods, such as beetroot juice. Study Details The placebo-controlled, double-blind crossover trial involved 39 participants under 30 and 36 healthy elderly individuals 60-70 years of age. Individuals from both the group consumed the nitrate-rich beetroot juice (750 mg of nitrate) daily for 2 weeks and then, after a 2-week washout period, a placebo version of the juice without nitrate. Researchers analyzed the oral microbiomes of the participants through gene sequencing before and after a 2-week regimen of twice-daily antiseptic mouthwash use. Key Findings At baseline, the microbiome did not differ between younger and older adults. After consuming nitrate-rich juice, individuals from both groups showed changes, but the effects differed. In older adults, harmful bacteria such as Prevotella decreased, whereas beneficial bacteria such as Neisseria increased. This shift was associated with higher nitrite levels. Older participants had a slightly higher average blood pressure (126/80 mm Hg). With nitrate-rich juice, their blood pressure dropped by approximately 7 mm Hg. No effect was seen with placebo juice or in younger adults who already had normal blood pressure. These findings suggest that nitrate lowers blood pressure by reducing harmful oral bacteria and improving the conversion of nitrate to nitric oxide. This mechanism may be particularly important in older adults as natural nitric oxide production declines with age. Foods rich in nitrate, such as spinach, arugula, fennel, celery, and kale, may provide similar benefits. Larger studies are needed to confirm these effects in older adults. This story was translated from Coliquio.
Medscape
an hour ago
- Medscape
UK Clinicians Want Clearer AI Guidance and Oversight
Artificial intelligence (AI) is playing a growing role in healthcare worldwide, but UK clinicians remain cautious, citing practical and ethical concerns, research has revealed. Alongside rising global adoption, regulators are moving to address safety and trust. The Medicines and Healthcare products Regulatory Agency (MHRA) has joined as a founding member of the new Health AI Global Regulatory Network, positioning the UK at the forefront of international oversight. Global Uptake Rising, UK Lags Behind Elsevier's Clinician of the Future 2025 report, published last month, surveyed 2206 clinicians (1781 doctors and 425 nurses) in 109 countries. The responses included answers from 78 UK doctors or physician associates and 31 nurses. Nearly half of respondents globally (48%) reported using AI at work, almost double the 2024 figure of 26%. In the UK, uptake was lower. Only 34% of UK clinicians reported using AI at work, with just 21% of doctors doing so. Common uses included identifying drug interactions (20%), writing clinical notes (18%), second opinions (18%), patient letters (16%), analysing medical images (15%), medication summaries (12%), and multidisciplinary reviews of complex cases (8%). Despite high patient volumes — 60% of UK clinicians said they lacked time to deliver good care, compared with 74% globally — many felt digital diagnostic tools remained inadequate. Scepticism and Distrust UK clinicians were more sceptical than average about AI's potential benefits and were less likely to use it for clinical decision-making, with 53% indicating they would not, and 45% saying they would not rely on AI tools for second opinions. Thirty-three percent described AI as unreliable, compared with 23% who considered it trustworthy. Dr Rahul Goyal, clinical executive at Elsevier and a practising GP, told Medscape News UK that caution reflects the NHS's structure. He cited strict regulatory oversight, national guidelines, evidence-based practice, and accountability as factors. 'While these priorities help safeguard patient care, they can also make clinicians more cautious about adopting new technologies like AI,' he said. He also pointed to 'tech debt' within NHS systems, with many still paper-based and lacking routine clinical decision support. 'As a result, clinicians are understandably more sceptical about using new technologies,' Goyal said. Confidentiality and Trust Most Key When asked what would increase their confidence in AI, 81% of UK clinicians highlighted data confidentiality. The same proportion wanted AI tools trained for factual accuracy, morality, and safety — well above the 63% global average. Trust in international governance was low. Just 27% of UK respondents said they trusted their organisation's AI oversight. Globally, 74% said clearer guidance on AI use would boost trust. The findings align with concerns expressed in Medscape's September 2024 UK Doctors and AI Report. It found that while more than half of clinicians were enthusiastic about the future of AI in healthcare, 1 in 3 of the 745 respondents lacked confidence that it could ensure confidentiality. The vast majority (83%) agreed there was a need for oversight of AI in healthcare settings. Push for Regulation A General Medical Council report earlier this year echoed these concerns, with doctors warning that NHS IT systems must improve before wider adoption. Respondents highlighted concerns about confidentiality risks, over-reliance, de-skilling, errors, and lack of independent evaluation. Many called for regulators to provide more guidance. The lower adoption rate of AI in the UK 'underscores the prevailing caution, and reinforces the need for greater integration, clear guidance, and reassurance as AI becomes more prominent in UK healthcare,' Goyal said. He expressed support for the MHRA's leading role in the new Health AI Global Regulatory Network, describing it as 'a proactive step toward addressing clinicians' concerns.' AI and digital tools are reshaping healthcare, he said, but 'their success depends on building systems that empower clinicians to use them confidently and responsibly.' Looking Ahead While concerns persist, many clinicians see potential benefits. Nearly half (46%) of UK respondents said AI could improve consultation quality, and 62% expected it to improve patient outcomes within 3 years. Goyal said that success depends on integration into NHS systems, clinician training, and patient acceptance. 'If AI is used as a tool to improve access, enhance communication, and empower patients with information, then it is a win,' he said. 'However, if it is poorly implemented or perceived as impersonal, it could widen the gap between GPs and patients.'
